Amsterdam | 14 October 2021 | Leader Biomedical Europe B.V. received new ISO certificate with number MD656674 from BSI for extended scope of: “Design, development…
Malaysia | Amsterdam | 17 January 2020 | Intran Technologies inked a collaboration with Leader Biomedical, the renowned Netherlands based medical devices group in establishing…
India | 16 December 2019 | Leader Biomedical‘s Vebroplast®, radiopaque vertebroplasty spine cement, has been cleared by Central Drugs Standard Control Organization (CDSCO) for registration…
Amsterdam | 15 November 2019 | Leader Biomedical’s Adcon® Gel – anti-adhesion gel – is reviewed, approved and extended by notified body DEKRA to 30…
Amsterdam | 30 July 2019 | Leader Biomedical adds new accessories to its Joint Care Reconstruction portfolio with VarioPlug® resorbable, biodegradable cement restrictor and Pulse…
Amsterdam | 28 May 2019 | Leader Biomedical introduces Hyalosyn™ Gel, a 1% sodium hyaluronate viscoelastic sterile solution, manufactured by synthetic fermentation, with no microbiological…
Amsterdam | 19 July 2018 | Leader Biomedical introduces new Spine Portfolio with the launch of three targeted therapeutic solutions Adcon® Gel, Hyalosyn™ Gel, and…
Amsterdam | Geisingen | 27 February 2018 | Leader Biomedical is pleased to announce the phased acquisition of International Orthopaedics Holding GmbH (International Orthopaedics), a…
Urolastic™ Urinary Stress Incontinence AMSTERDAM | MALAYSIA- Urogyn B.V. and Leader Biomedical announce the first patient treated in Malaysia with Urolastic™– an innovative Urinary Stress…
Urogyn B.V. and Leader Biomedical are proud to announce another milestone in their collaboration, with the launch of Urolastic™ – an innovative Urinary Stress Incontinence…